Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hepalink Strengthens Biologics Presence With OncoVent JV

This article was originally published in PharmAsia News

Executive Summary

China's Shenzhen Hepalink, a public company that claims to be one of the largest makers of heparin in the world, is aiming to build up its R&D activities for biologics through a newly formed Chinese JV with OncoQuest, which will leverage the two companies’ expertise and assets to develop novel cancer immunotherapies.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC089477

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel